News and Trends 20 Dec 2022
Watch: IRLAB CEO Richard Godfrey
IRLAB discovers and develops novel treatments of Parkinson’s disease and other CNS disorders. The company's most advanced drug candidates, mesdopetam (IRL790) and pirepemat (IRL752), are in phase IIb and are…
